Horsham, United Kingdom

Peter David Edwards

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter David Edwards

Introduction

Peter David Edwards is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsant medications. His work has the potential to impact the lives of many individuals suffering from seizure disorders.

Latest Patents

One of his key patents is titled "Substituted isoquinoline derivatives and their use as anticonvulsants." This invention focuses on the development of substituted isoquinoline derivatives, which are designed to serve as effective anticonvulsant agents. The patent highlights the innovative approach taken by Edwards in addressing the challenges associated with seizure management.

Career Highlights

Peter David Edwards has had a distinguished career, working with SmithKline Beecham Corporation, a leading pharmaceutical company. His role at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Throughout his career, Edwards has worked alongside notable colleagues such as Robert William Ward and Mervyn Thompson. These collaborations have fostered a creative environment that has led to the development of groundbreaking inventions in the pharmaceutical industry.

Conclusion

Peter David Edwards is a prominent figure in the realm of pharmaceutical innovation, with a focus on anticonvulsant research. His contributions, particularly through his patent on substituted isoquinoline derivatives, demonstrate his commitment to improving medical treatments. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…